BioCentury
ARTICLE | Company News

Chiron receives approval in Ireland

August 8, 2000 7:00 AM UTC

CHIR received marketing approval in Ireland for its Menjugate conjugate vaccine against meningococcal C disease in patients aged 12 months and older. Menjugate, which will be co-promoted in Ireland by...